Since insulin resistance and bone metabolism share a similar pathophysiology, abnormal signaling of insulin could cause dysregulation of osteoblast activity and osteoclast differentiation, leading to bone damage and osteoporosis.9, 10. The gene discussed is INS; the disease is osteoporosis.